NYSE:DHRLife Sciences
Assessing Danaher (DHR) Valuation After 2025 Sales Growth But Weaker Earnings
Danaher (DHR) has released its full year 2025 results, reporting sales of US$24.6b compared to US$23.9b a year earlier, while net income and earnings per share were lower than the prior year.
See our latest analysis for Danaher.
The full-year update, with sales of US$24.6b alongside lower net income and earnings per share, comes after a mixed price picture. The share price showed a 2.07% 1-day return but has declined 3.03% year to date. Over a longer horizon, total shareholder return has been...